Among the kinases, EGFR kinase is a promising target due to the overexpression of EGFR in pancreatic cancers; in particular, a treatment strategy mediated by nanoparticles targeting the EGFR ligand has been reported for pancreatic cancers [15,16]. Here, EGFR is linked to pancreatic neoplasm.